Abstract:Objective To study the regulatory effect of longchain noncoding RNA (lncRNA) DLEU2 on microRNA (miR) 4103p and its effect on the proliferation, migration and invasion of rheumatoid arthritis (RA) synovial fibroblasts. Methods qRTPCR was used to detect the expression of DLEU2 and miR4103p in the synovial tissue of patients with rheumatoid arthritis. LncBase Predicted v.2 prediction and dual luciferase reporting experiments analyzed the targeting relationship between DLEU2 and miR4103p. Transfected siDLEU2 or miR4103p, or cotransfected siDLEU2 and antimiR4103p in RA synovial fibroblasts MH7A. MTT, Transwell, and Western blot were applied to determine the proliferation, migration, invasion and expression of CyclinD1, p21, Matrix metalloprotease (MMP)2, and MMP9 in RA synovial fibroblasts MH7A. Results The expression of DLEU2 in synovial tissue of RA patients increased significantly, and the expression of miR4103p decreased dramatically (P<0.05). lncRNA DLEU2 targeted the regulation of miR4103p expression. Inhibition of DLEU2 expression or miR4103p overexpression obviously reduced OD values of RA synovial fibroblasts MH7A at 24 h, 48 h and 72 h, migrating cells, invasive cells, levels of CyclinD1, MMP2, and MMP9 proteins, but evidently enhanced the expression level of p21 protein (P<0.05). Interfering with the expression of miR4103p reversed the inhibition of DLEU2 expression on the proliferation and migration of RA synovial fibroblasts MH7A. Conclusion lncRNA DLEU2 is upregulated in rheumatoid arthritis synovial tissues, and inhibition of its expression inhibits the proliferation, migration and invasion of rheumatoid arthritis synovial fibroblasts by targeting miR-410-3p.